Cerus Corp. Company Profile (NASDAQ:CERS)

Analyst Ratings

Consensus Ratings for Cerus Corp. (NASDAQ:CERS) (?)
Ratings Breakdown: 1 Hold Rating(s), 6 Buy Rating(s)
Consensus Rating:Buy (Score: 2.86)
Consensus Price Target: $8.90 (33.83% upside)

Analysts' Ratings History for Cerus Corp. (NASDAQ:CERS)
Show:
DateFirmActionRatingPrice TargetActions
7/11/2016FBR & CoReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/7/2016Cantor FitzgeraldReiterated RatingNot Available -> Buy$9.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/22/2016Robert W. BairdReiterated RatingOutperform$9.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/20/2016BTIG ResearchReiterated RatingBuy$10.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/6/2016StephensReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/29/2016Cowen and CompanyReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/17/2015WedbushDowngradeOutperform -> Neutral$6.50View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/30/2015MLV & Co.Reiterated RatingBuy$10.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/25/2014 forward)

Earnings

Earnings History for Cerus Corp. (NASDAQ:CERS)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
8/4/2016        
5/3/2016Q1($0.16)($0.17)$8.29 million$7.60 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/8/2016Q415($0.16)($0.15)$9.72 million$9.70 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/5/2015Q315($0.16)($0.17)$10.00 million$8.04 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/6/2015Q215($0.15)($0.17)$8.71 million$8.83 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/5/2015Q214($0.16)($0.17)$7.70 million$7.70 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/26/2015Q114($0.15)($0.25)$10.36 million$9.70 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/4/2014Q413($0.13)($0.15)$9.83 million$10.36 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/31/2014Q313($0.13)($0.16)$8.17 million$8.60 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/1/2014Q313($0.12)($0.12)$9.65 million$7.86 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/25/2014Q213($0.09)($0.10)$11.77 million$9.23 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/29/2013($0.09)($0.29)$10.34 million$10.54 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Cerus Corp. (NASDAQ:CERS)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161($0.17)($0.17)($0.17)
Q2 20161($0.16)($0.16)($0.16)
Q3 20161($0.16)($0.16)($0.16)
Q4 20161($0.16)($0.16)($0.16)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Cerus Corp. (NASDAQ:CERS)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Cerus Corp. (NASDAQ:CERS)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
8/19/2015Laurence M CorashInsiderBuy25,900$4.99$129,241.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/18/2015Laurence M CorashInsiderBuy84,600$4.77$403,542.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/10/2014William Mariner GreenmanCEOBuy21,800$3.93$85,674.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/19/2012William Mariner GreenmanCEOBuy3,200$3.02$9,664.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/16/2012Laurence M CorashInsiderBuy2,000$2.85$5,700.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/16/2012William Mariner GreenmanCEOBuy13,800$2.85$39,330.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Cerus Corp. (NASDAQ:CERS)
DateHeadline
07/22/16 03:10 PMAnalyst Rating Fluctuations to Observe: UnitedHealth Group Incorporated (NYSE:UNH) , Cerus Corporation (NASDAQ ... - Street Updates
07/22/16 03:10 PMAnalyst Rating Fluctuations to Observe: UnitedHealth Group (NYSE:UNH) , Cerus Corporation (NASDAQ:CERS) - Street Updates
07/22/16 11:19 AMCerus to Release Second Quarter 2016 Results on …
07/21/16 07:30 AMCerus to Release Second Quarter 2016 Results on August 4, 2016 - [Business Wire] - Cerus Corporation announced today that its second quarter results will be released on Thursday, August 4, 2016, after the close of the stock market. The company will host a conference call and webcast at 4:15 PM ET that afternoon, during which management will discuss the Company’s financial results and provide a general business overview and outlook.
07/21/16 06:51 AMCerus Corporation (CERS) is Trading Higher on Unusual Volume for July 19 - Equities.com
07/19/16 03:12 PMMid-Morning Market Update: Markets Edge Lower; Goldman Sachs Profit Beats Estimates
07/14/16 09:16 AMStocks within Analysts Spotlight: Horizon Pharma plc (NASDAQ:HZNP) , Cerus Corporation (NASDAQ:CERS) - Street Updates
07/14/16 09:16 AMCerus Corporation (NASDAQ:CERS) Shorted Shares Increased 6.32% After Market Selling - Consumer Eagle
07/14/16 09:16 AMBroker Outlook For Cerus Corporation (CERS) - Fiscal Standard
07/12/16 07:22 AMStocks Analysts Ranking Summary: Cerus Corporation (NASDAQ:CERS) , Novo Nordisk A/S (NYSE:NVO) - Street Updates
07/11/16 07:53 AMCerus Provides an Update on Adoption by Blood Centers of America Members for the INTERCEPT Blood System for Platelets and Plasma - [at noodls] - CONCORD, Calif.--(BUSINESS WIRE)-- Cerus Corporation (NASDAQ:CERS) announced today that blood center members representing 54% of the aggregate volume of platelets produced by Blood Centers of America (BCA) ...
07/10/16 07:49 AMCerus Corporation (NASDAQ:CERS) Shorted Shares Increased By 6.32% - Press Telegraph
07/08/16 01:01 PMCORRECTING and REPLACING Cerus to Present at Cantor Fitzgerald’s 2nd Annual Healthcare Conference on July 13, 2016 - [at noodls] - CONCORD, Calif.--(BUSINESS WIRE)-- In the first paragraph, presentation time should read 1:00 PM ET (instead of 1:30 PM ET). ... This is an abstract of the original noodl. To continue reading this document, ...
07/06/16 07:55 AMCerus to Present at Cantor Fitzgerald's 2nd …
07/06/16 07:30 AMCerus and CEI Announce Donation of INTERCEPT Blood System Kits to HEMORIO for Emergency Preparedness Ahead of the Summer Olympic Games in Rio de Janeiro - [Business Wire] - Cerus Corporation and its distribution partner CEI Group today announced a donation of INTERCEPT Blood System pathogen reduction kits for platelets and plasma to HEMORIO, a public hospital responsible for transfusion medicine and hematology care for the state of Rio de Janeiro and part of the State Health Department and coordinator of the State Blood Network.
07/05/16 07:30 AMCerus to Present at Cantor Fitzgerald’s 2nd Annual Healthcare Conference on July 13, 2016 - [Business Wire] - Cerus Corporation announced today that Kevin Green, Cerus' vice president, finance and chief financial officer, is scheduled to present a corporate update at the Cantor Fitzgerald Healthcare Conference at 1:30 PM ET on Wednesday, July 13, 2016.
07/04/16 03:01 PMShare Performance Recap for: Cerus Corporation (NASDAQ:CERS) - Press Telegraph
07/04/16 03:01 PMBroker Outlook For The Week Ahead Cerus Corporation (CERS) - Fiscal Standard
07/02/16 10:46 AMAnalyst Rating Update on Cerus Corporation (CERS) - TheFounders Daily
07/01/16 03:11 PMAnalyst Recommended Stock: Cerus Corporation (NASDAQ:CERS) - News Oracle
07/01/16 03:11 PMCerus Corporation (NASDAQ:CERS) Receives $2 Million For Blood Safety Program For Africa - Market Exclusive
07/01/16 03:11 PMCerus Corporation (CERS) Current Analyst Ratings - Fiscal Standard
07/01/16 11:12 AMCerus Corporation (NASDAQ:CERS) Receives $2 Million For Blood Safety Program For Africa
06/30/16 07:32 AM8:32 am Cerus receives a grant of CHF 2 mln from the Swiss Red Cross Humanitarian Foundation -
06/30/16 07:30 AMCerus Corporation, the Transfusion Service of the Swiss Red Cross, and the University Hospital of Basel Receive a Grant of 2 Million Swiss Francs From the Swiss Red Cross Humanitarian Foundation for Whole Blood Pathogen Inactivation for Afr - [Business Wire] - Cerus Corporation , announced today that the Swiss Red Cross Humanitarian Foundation has awarded a grant of 2 million Swiss Francs to Cerus, the University Hospital of Basel, and the Swiss Transfusion SRC to complete the necessary clinical studies to develop a whole blood pathogen inactivation system for use in Africa.
06/29/16 08:13 PMWill Senate Recess Without Approving Zika Funding Amid Mosquito Season? - Benzinga
06/29/16 08:13 PMCerus Corporation Stock Momentum Hits Strength - CML News
06/27/16 03:04 PMWhy Investors Have These Biotech Stocks on Their Radar? - Cerus, Juno Therapeutics, Chiasma, and Sage Therapeutics
06/27/16 07:45 AMWhy Investors Have These Biotech Stocks on Their Radar? - Cerus, Juno Therapeutics, Chiasma, and Sage ... - PR Newswire (press release)
06/26/16 08:18 AMCerus Corporation (NASDAQ:CERS) Shorted Shares Increased By 6.32% - Engelwood Daily
06/23/16 10:55 AMRecently Issued Stock Ratings For Cerus Corporation (CERS) - Fiscal Standard
06/23/16 10:55 AMCerus Corporation (CERS) Updated Price Targets - FTSE News
06/22/16 03:18 PMCerus Corporation (CERS) Jumps 7.72% on June 20 - Equities.com
06/22/16 03:18 PMBaird Bullish on EXACT Sciences Corporation (EXAS) and Cerus Corporation (CERS); Here's Why - Smarter Analyst
06/21/16 03:01 PMUS to help fund technology to eliminate Zika in blood supply
06/21/16 03:01 PMAnalyst’s Review to Watch: Cerus Corporation (NASDAQ:CERS)
06/21/16 10:23 AMCerus Corp. – Value Analysis (NASDAQ:CERS) : June 21, 2016 -
06/21/16 07:54 AMHC Trending Hot Stocks: Cerus Corporation (NASDAQ:CERS), Hologic, Inc. (NASDAQ:HOLX) - share market updates (press release)
06/21/16 07:54 AM5 Health Care Equipment & Supplies Stocks to Buy Now - Investorplace.com
06/21/16 07:54 AMPre-Market Investor's Alert: GlobeImmune Inc(NASDAQ:GBIM), Cerus Corporation(NASDAQ:CERS) - iStreetWire
06/20/16 03:08 PMCerus snags up to $180M from BARDA for blood pathogen reduction system
06/20/16 03:08 PMCerus inks 5-year contract with BARDA potentially worth $180.5M to develop INTERECEPT for pathogen reduction of red blood cell components
06/20/16 12:03 PMCerus Corporation is Surging Today. Here's Why. - Shares of the blood-transfusion specialist are on the move after news broke that it has won a lucrative government contract.
06/20/16 09:31 AMCerus Corporation (CERS) Bursts Higher on BARDA Funding
06/20/16 09:31 AMCerus Announces Agreement with BARDA for Potential Funding of up to Approximately $180 Million to Advance Its INTERCEPT Red Blood Cell Program
06/20/16 09:31 AMCerus : CERS Gets BARDA Funding, EPZM Abuzz, ZSAN Awaits Data In Q1 2017
06/20/16 09:31 AMCerus, Terumo land $48m in BARDA grants for anti-Zika push
06/20/16 09:31 AMCerus (CERS) Inks Agreement with BARDA for RBC Component Pathogen Reduction Program
06/20/16 07:26 AMCerus Corp. breached its 50 day moving average in a Bearish Manner : CERS-US : June 20, 2016 -
06/19/16 03:01 PMCerus Announces Agreement with BARDA for Potential Funding of up to Approximately $180 Million to Advance Its ... - Business Wire (press release)

Social

About Cerus Corp.

Cerus Corp. logoCerus Corporation is a biomedical products company. The Company is engaged in developing and commercializing the INTERCEPT Blood System for blood safety. The Company operates through blood safety segment. The Company's INTERCEPT Blood System is based on its technology for controlling biological replication, and is designed to reduce blood-borne pathogens in donated blood components intended for transfusion. The Company's INTERCEPT Blood System is designed to target and inactivate blood-borne pathogens, such as viruses, including human immunodeficiency virus (HIV), West Nile, Severe acute respiratory syndrome (SARS), hepatitis B and C; bacteria and parasites, as well as harmful white blood cells, while preserving the therapeutic properties of platelet, plasma and red blood cell transfusion products. The Company's INTERCEPT Blood System is for use with blood components, including plasma, platelets, and red blood cells.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: Health Care Supplies
  • Exchange: NASDAQ
  • Symbol: CERS
  • CUSIP: 15708510
Key Metrics:
  • Previous Close: $6.65
  • 50 Day Moving Average: $6.19
  • 200 Day Moving Average: $5.81
  • P/E Ratio: N/A
  • P/E Growth: 0.00
  • Market Cap: $676.37M
  • Beta: 1.89
  • Current Year EPS Consensus Estimate: $-0.65 EPS
  • Next Year EPS Consensus Estimate: $-0.50 EPS
Additional Links:
Cerus Corp. (NASDAQ:CERS) Chart for Monday, July, 25, 2016